P. Wolna

发表

Open-label, single-center, phase I trial to investigate the mass balance and absolute bioavailability of the highly selective oral MET inhibitor tepotinib in healthy volunteers

A. Johne, H. Scheible, A. Becker, 2020, Investigational New Drugs.

Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects

R. Hermann, N. Fauchoux, A. Johne, 2012, Biopharmaceutics & drug disposition.

Cardiotoxicity of chlorodibromomethane and trichloromethane in rats and isolated rat cardiac myocytes

P. Wolna, D. Pankow, U. Wünscher, 1997, Archives of Toxicology.

Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris®) in Pituitary-Suppressed Healthy Women

Ö. Yalkinoglu, P. Wolna, W. Bagchus, 2018, Front. Endocrinol..

Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo‐ and Racemic Praziquantel: Two Phase I Studies

D. Bezuidenhout, P. Wolna, O. Yalkinoglu, 2018, Clinical and translational science.

New levothyroxine formulation meeting 95–105% specification over the whole shelf-life: results from two pharmacokinetic trials

G. Kahaly, P. Wolna, W. Uhl, 2017, Current medical research and opinion.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects

Daniel P. Willen, O. Papasouliotis, Ö. Yalkinoglu, 2019, European Journal of Drug Metabolism and Pharmacokinetics.

Efficacy and Safety of a Butcher’s Broom Preparation (Ruscus aculeatus L. Extract) Compared to Placebo in Patients Suffering from Chronic Venous Insufficiency

P. Wolna, W. Vanscheidt, P. Lücker, 2002, Arzneimittelforschung.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects

O. Papasouliotis, Ö. Yalkinoglu, P. Wolna, 2019, European Journal of Drug Metabolism and Pharmacokinetics.

Comparison of the pharmacokinetics, safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulation

B. Liedert, A. Kovar, P. Wolna, 2010, BMC clinical pharmacology.

Effect of ceralifimod (ONO‐4641) on lymphocytes and cardiac function: Randomized, double‐blind, placebo‐controlled trial with an open‐label fingolimod arm

U. Boschert, B. Darpo, P. Wolna, 2015, Journal of clinical pharmacology.

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women

P. Wolna, W. Uhl, W. Bagchus, 2017, Reproductive medicine and biology.

Nonlinear dynamic processes in open single enzyme systems.

G. Hübner, P. Wolna, 1994, Biological chemistry Hoppe-Seyler.